Core Viewpoint - Recently, JianShi Technology (09877) has been awarded the "2025 Excellent Domestic Medical Device Consumables Selection" for its transcatheter aortic valve replacement system, highlighting its recognition in the medical device industry [1] Group 1: Product Features - The Ken-Valve transcatheter intervention replacement system is designed for severe aortic regurgitation (or combined stenosis), featuring an original design that adapts to a wide range of complex anatomical structures [1] - The device enhances operational safety and flexibility during procedures, significantly reducing instrument operation time, which has gained broad recognition from practitioners and the market [1] - The availability of large sizes (29mm, 31mm, and 33mm) addresses the treatment needs of patients with large annuli that are currently unmet in the market [1] Group 2: Market Position and Strategy - The device is also applicable for patients with complex anatomical challenges, such as those with extreme angulation [1] - The company is actively promoting the commercialization of this product, aiming to meet the urgent clinical needs of a wide range of underserved patients [1]
健世科技荣获“2025年度长三角优秀国产医疗设备耗材遴选”医用耗材类推荐产品